Salvatori R, Serpa M G, Parmigiani G, Britto A V O, Oliveira J L M, Oliveira C R P, Prado C M, Farias C T, Almeida J C, Vicente T A R, Aguiar-Oliveira M H
Division of Endocrinology, Department of Medicine, The Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA.
J Endocrinol Invest. 2006 Oct;29(9):805-8. doi: 10.1007/BF03347374.
GH secretion by the pituitary is the result of the balance between the stimulatory effect of GHRH and the inhibitory effect of SS. Patients with mutations in GHRH receptor (GHRH-R) gene (GHRH-R) offer a unique model to study the mechanism of action of different GH secretion stimuli. In the past, we have demonstrated a small but significant GH response to a GH secretagogue (GHRP-2) in a homogenous cohort of patients with severe GH deficiency (GHD) due to a homozygous null mutation in GHRH-R (IVS1+1G-->A). Now, we sought to determine if we could detect a GH response to hypoglycemia (ITT: insulin tolerance test) or clonidine (CL) in these patients. Nine young GHD subjects underwent both ITT and CL tests, and 2 additional subjects underwent only CL test. There was a small but significant GH increase during ITT, but not during CL test. These results indicate that a minimal albeit significant GH response to ITT can occur despite complete lack of GHRH-R function.
垂体分泌生长激素(GH)是生长激素释放激素(GHRH)的刺激作用与生长抑素(SS)的抑制作用之间平衡的结果。生长激素释放激素受体(GHRH-R)基因发生突变的患者为研究不同生长激素分泌刺激的作用机制提供了独特的模型。过去,我们已经证明,在一组因GHRH-R(IVS1+1G→A)纯合无效突变而导致严重生长激素缺乏(GHD)的同质患者中,生长激素促分泌素(GHRP-2)能引起较小但显著的生长激素反应。现在,我们试图确定在这些患者中是否能检测到对低血糖(胰岛素耐量试验:ITT)或可乐定(CL)的生长激素反应。9名年轻的生长激素缺乏受试者接受了ITT和CL试验,另外2名受试者仅接受了CL试验。ITT期间生长激素有小幅但显著的升高,而CL试验期间则没有。这些结果表明,尽管完全缺乏GHRH-R功能,但对ITT仍可出现最小程度但显著的生长激素反应。